Chimera Investment
278 hedge funds and large institutions have $1.4B invested in Chimera Investment in 2022 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 87 increasing their positions, 95 reducing their positions, and 38 closing their positions.
238% more call options, than puts
Call options by funds: $22.5M | Put options by funds: $6.66M
3% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 38
8% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 95
1.32% less ownership
Funds ownership: 17.7% → 16.38% (-1.3%)
2% less funds holding
Funds holding: 285 → 278 (-7)
26% less capital invested
Capital invested by funds: $1.89B → $1.4B (-$490M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$11.8M |
| 2 |
Millennium Management
New York
|
+$11.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$6.85M |
| 4 |
Renaissance Technologies
New York
|
+$6.17M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$5.83M |
Top Sellers
CIM Hedge Fund Activity: Q1 2022 in Review
278 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Chimera Investment (CIM) for Q1 2022, worth a combined $1.4B — down 26% from $1.89B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of CIM and 37 opened new positions — a net loss of 1 holder — while 95 trimmed existing stakes and 87 added.
The largest buyer was Goldman Sachs, adding an estimated $11.8M. The largest seller was Arrowstreet Capital, cutting an estimated $75M.
- 278 institutional investors held Chimera Investment (CIM) as of Q1 2022, down from 285 in Q4 2021.
- Funds reported $1.4B of Chimera Investment stock for Q1 2022, down 26% quarter-over-quarter.
- 37 funds opened new Chimera Investment positions in Q1 2022 and 38 closed out, a net change of -1 holder.
- The largest Chimera Investment buyer in Q1 2022 was Goldman Sachs, an estimated $11.8M added.
- The largest Chimera Investment seller in Q1 2022 was Arrowstreet Capital, an estimated $75M sold.
Based on aggregated 13F filings for Q1 2022.